Peak6 Investments LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$193.33 - $291.99 $1.31 Million - $1.99 Million	6,800 Added 971.43%	7,500 $2.1 Million
Q1 2024 May 14, 2024	SELL	$171.37 - $283.23 $394,151 - $651,429	-2,300 Reduced 76.67%	700 $186,000
Q4 2023 Feb 13, 2024	BUY	$120.4 - $237.13 $204,680 - $403,121	1,700 Added 130.77%	3,000 $694,000
Q3 2023 Nov 13, 2023	SELL	$146.04 - $225.78 $2.45 Million - $3.79 Million	-16,800 Reduced 92.82%	1,300 $189,000
Q2 2023 Aug 11, 2023	SELL	$203.88 - $312.0 $224,268 - $343,200	-1,100 Reduced 5.73%	18,100 $4.18 Million
Q1 2023 May 12, 2023	SELL	$231.06 - $307.08 $2.01 Million - $2.67 Million	-8,700 Reduced 31.18%	19,200 $4.65 Million
Q4 2022 Feb 10, 2023	BUY	$58.39 - $296.54 $1.63 Million - $8.27 Million	27,900 New	27,900 $8.1 Million

298

22M

757K

370K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.63B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.